Original language | English |
---|---|
Pages (from-to) | 1995-2051 |
Number of pages | 57 |
Journal | The Lancet |
Volume | 392 |
Issue number | 10159 |
DOIs | |
Publication status | Published (VoR) - 1 Nov 2018 |
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet, Vol. 392, No. 10159, 01.11.2018, p. 1995-2051.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Population and fertility by age and sex for 195 countries and territories, 1950–2017
T2 - a systematic analysis for the Global Burden of Disease Study 2017
AU - GBD 2017 Population and Fertility Collaborators
AU - Murray, Christopher J.L.
AU - Callender, Charlton S.K.H.
AU - Kulikoff, Xie Rachel
AU - Srinivasan, Vinay
AU - Abate, Degu
AU - Abate, Kalkidan Hassen
AU - Abay, Solomon M.
AU - Abbasi, Nooshin
AU - Abbastabar, Hedayat
AU - Abdela, Jemal
AU - Abdelalim, Ahmed
AU - Abdel-Rahman, Omar
AU - Abdi, Alireza
AU - Abdoli, Nasrin
AU - Abdollahpour, Ibrahim
AU - Abdulkader, Rizwan Suliankatchi
AU - Abebe, Haftom Temesgen
AU - Abebe, Molla
AU - Abebe, Zegeye
AU - Abebo, Teshome Abuka
AU - Abejie, Ayenew Negesse
AU - Aboyans, Victor
AU - Abraha, Haftom Niguse
AU - Abreu, Daisy Maria Xavier
AU - Abrham, Aklilu Roba
AU - Abu-Raddad, Laith Jamal
AU - Abu-Rmeileh, Niveen M.E.
AU - Accrombessi, Manfred Mario Kokou
AU - Acharya, Pawan
AU - Adamu, Abdu A.
AU - Adebayo, Oladimeji M.
AU - Adedeji, Isaac Akinkunmi
AU - Adekanmbi, Victor
AU - Adetokunboh, Olatunji O.
AU - Adhena, Beyene Meressa
AU - Adhikari, Tara Ballav
AU - Adib, Mina G.
AU - Adou, Arsène Kouablan
AU - Adsuar, Jose C.
AU - Afarideh, Mohsen
AU - Afshin, Ashkan
AU - Agarwal, Gina
AU - Agesa, Kareha M.
AU - Aghayan, Sargis Aghasi
AU - Agrawal, Sutapa
AU - Ahmadi, Alireza
AU - Ahmadi, Mehdi
AU - Ahmed, Muktar Beshir
AU - Ahmed, Sayem
AU - Aremu, Olatunde
N1 - Funding Information: Adam Berman reports personal fees from Philips. Cyrus Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda, and UCB. Mir Sohail Fazeli reports personal fees from Doctor Evidence LLC. Panniyammakal Jeemon reports a Clinical and Public Health Intermediate Fellowship from the Wellcome Trust-DBT India Alliance (2015–20). Jacek Jóźwiak reports a grant from Valeant, personal fees from Valeant, ALAB Laboratoria and Amgen, and non-financial support from Microlife and Servier. Nicholas Kassebaum reports personal fees and other support from Vifor Pharmaceuticals, LLC. Srinivasa Vittal Katikireddi reports grants from NHS Research Scotland (no. SCAF/15/02), the Medical Research Council (MC_UU_12017/13 and MC_UU_12017/15), and Scottish Government Chief Scientist Office (SPHSU13 and SPHSU15). Jeffrey Lazarus reports personal fees from Janssen and CEPHEID and grants and personal fees from AbbVie, Gilead Sciences, and MSD. Winfried März reports grants and personal fees from Siemens Diagnostics, Aegerion Pharmaceuticals, Amgen, AstraZeneca, Danone Research, Pfizer, BASF, Numares AG, and Berline-Chemie; personal fees from Hoffmann LaRoche, MSD, Sanofi, and Synageva; grants from Abbott Diagnostics; and other support from Synlab Holding Deutschland GmbH. Walter Mendoza is currently a Program Analyst for Population and Development at the Peru Country Office of the United Nations Population Fund (UNFPA), which does not necessarily endorse this study. Ted Miller reports an evaluation contract from AB InBev Foundation. Guilherme Polanczyk reports personal fees from Shire, Teva, Medice, and Editora Manole. Maarten Postma reports grants from Mundipharma, Bayer, BMS, AstraZeneca, ARTEG, and AscA; grants and personal fees from Sigma Tau, MSD, GSK, Pfizer, Boehringer-Ingelheim, Novavax, Ingress Health, AbbVie, and Sanofi; personal fees from Quintiles, Astellas, Mapi, OptumInsight, Novartis, Swedish Orphan, Innoval, Jansen, Intercept, and Pharmerit, and stock ownership in Ingress Health and Pharmacoeconomics Advice Groningen. Kenji Shibuya reports grants from Ministry of Health, Labour, and Welfare and from Ministry of Education, Culture, Sports, Science, and Technology. Cassandra Szoeke reports a grant from the National Medical Health Research Council, Lundbeck, Alzheimer's Association, and the Royal Australasian College of Practitioners; she holds patent PCT/AU2008/001556. Muthiah Vaduganathan receives research support from the NIH/NHLBI and serves as a consultant for Bayer AG and Baxter Healthcare. Marcel Yotebieng reports grants from the US National Institutes of Health. All remaining authors declare no competing interests. Funding Information: Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the University of Melbourne, Public Health England, the Norwegian Institute of Public Health, St Jude Children's Research Hospital, the National Institute on Ageing of the National Institutes of Health (award no. P30AG047845), and the National Institute of Mental Health of the National Institutes of Health (R01MH110163). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. Data for this research was provided by the Russia Longitudinal Monitoring survey, conducted by the National Research University Higher School of Economics, ZAO Demoscope, Carolina Population Center, University of North Carolina at Chapel Hill, and the Institute of Sociology RAS. This analysis uses data or information from the LASI Pilot micro data and documentation. The development and release of the LASI Pilot Study was funded by the National Institute on Ageing and National Institutes of Health (R21AG032572, R03AG043052, and R01AG030153). The Palestinian Central Bureau of Statistics granted the researchers access to relevant data in accordance with license number SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law, 2000. The researchers are solely responsible for the conclusions and inferences drawn upon available data. Funding Information: Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the University of Melbourne, Public Health England, the Norwegian Institute of Public Health, St Jude Children's Research Hospital, the National Institute on Ageing of the National Institutes of Health (award no. P30AG047845) , and the National Institute of Mental Health of the National Institutes of Health (R01MH110163) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. Data for this research was provided by the Russia Longitudinal Monitoring survey, conducted by the National Research University Higher School of Economics, ZAO Demoscope, Carolina Population Center, University of North Carolina at Chapel Hill, and the Institute of Sociology RAS. This analysis uses data or information from the LASI Pilot micro data and documentation. The development and release of the LASI Pilot Study was funded by the National Institute on Ageing and National Institutes of Health (R21AG032572, R03AG043052, and R01AG030153) . The Palestinian Central Bureau of Statistics granted the researchers access to relevant data in accordance with license number SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law, 2000. The researchers are solely responsible for the conclusions and inferences drawn upon available data. Publisher Copyright: © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2018/11/1
Y1 - 2018/11/1
UR - http://www.scopus.com/inward/record.url?scp=85056166986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056166986&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(18)32278-5
DO - 10.1016/S0140-6736(18)32278-5
M3 - Article
C2 - 30496106
AN - SCOPUS:85056166986
SN - 0140-6736
VL - 392
SP - 1995
EP - 2051
JO - The Lancet
JF - The Lancet
IS - 10159
ER -